Moreover, mir-24 has also been found to inhibit β-cell proliferation and insulin secretion by targeting maturity-onset diabetes of the young (MODY) genes, Hnf1α and Neurod1 (Zhu et al., 2013). This evidence concerns the gene HNF1A and type 2 diabetes mellitus.